Academia Sinica and vaccine developer Moderna Inc. have agreed to jointly develop messenger ribonucleic acid (mRNA) technology and cultivate research talent in Taiwan under a five-year strategic partnership announced Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar down in Taipei trading
09/10/2026 10:16 AM - Business
Taiwan shares open lower
09/10/2026 09:15 AM - Politics
Lai welcomes new Palau envoy, thanks ally for int'l support
09/09/2026 08:47 PM - Society
MOL warns foodpanda over docking couriers' pay for late deliveries
09/09/2026 08:26 PM - Business
TSMC's market share hits record 72.5% in Q2
09/09/2026 08:15 PM